This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Saskatchewan directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Exploring attachment, trauma, and cannabis use in psychotic disorders: a qualitative study of patient and family perspectives.
BMC psychiatry · 2026
Δ9-Tetrahydrocannabinol (Δ9-THC) Improves Ischemia/Reperfusion Heart Dysfunction and Might Serve as a Cardioprotective Agent in the Future Treatment.
Frontiers in bioscience (Landmark edition) · 2022
Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study.
Frontiers in neurology · 2019
Latest funding
- $1,239,300
Advancing CB1R Cannabinoid Receptor Positive Allosteric Modulators for Novel Therapies in Temporal Lobe Epilepsy
CIHR · 2026 · Nominated PI
- $960,076
Cannabinoid-dependent effects of gestational Cannabis smoke exposure on behaviour and neurophysiology: implications for long-term offspring development
CIHR · 2024 · Principal investigator
- $6,000
Contributions of astrocytic cannabinoid type-1 receptors (CB1R) to metabolic dysfunction in mild traumatic brain injury
CIHR · 2023 · Supervisor
3 publications.
Exploring attachment, trauma, and cannabis use in psychotic disorders: a qualitative study of patient and family perspectives.
Carley S, Laprairie R, Adams S, Adams GC
Δ9-Tetrahydrocannabinol (Δ9-THC) Improves Ischemia/Reperfusion Heart Dysfunction and Might Serve as a Cardioprotective Agent in the Future Treatment.
Banaszkiewicz M, Tarwacka P, Krzywonos-Zawadzka A, Olejnik A, Laprairie R, Noszczyk-Nowak A, Sawicki G, Bil-Lula I
Dosage Related Efficacy and Tolerability of Cannabidiol in Children With Treatment-Resistant Epileptic Encephalopathy: Preliminary Results of the CARE-E Study.
Huntsman RJ, Tang-Wai R, Alcorn J, Vuong S, Acton B, Corley S, Laprairie R, Lyon AW, Meier S, Mousseau DD, Newmeyer D, Prosser-Loose E, Seifert B, Tellez-Zenteno J, Huh L, Leung E, Major P
Advancing CB1R Cannabinoid Receptor Positive Allosteric Modulators for Novel Therapies in Temporal Lobe Epilepsy
Principal investigators: Laprairie, Robert B; Botterill, Justin J; Thakur, Ganesh A
Keywords: Allosteric Modulation; Cannabinoid; Drug Discovery; Epilepsy; Molecular Biology; Neuroscience; Pharmacology; Structure-Activity Relationships; Type 1 Cannabinoid Receptor
Cannabinoid-dependent effects of gestational Cannabis smoke exposure on behaviour and neurophysiology: implications for long-term offspring development
Principal investigators: Howland, John G; Laprairie, Robert B
Keywords: Anxiety; Behaviour; Cannabinoid Receptor; Cognition; Cortex; Development; Imaging; Rna-Seq; Rodent Model
Contributions of astrocytic cannabinoid type-1 receptors (CB1R) to metabolic dysfunction in mild traumatic brain injury
Principal investigators: Black, Tallan A
Keywords: Cannabinoid Type-1 Receptor (Cb1r); Cerebral Metabolic Dysfunction; Mild Traumatic Brain Injuries (Mtbi); Neuroprotective; Traumatic Brain Injuries (Tbi)
The Effects and Mechanisms of Maternal Cannabis Smoke Exposure on the Developing Male and Female Rat Brain.
Principal investigators: Black, Tallan A
Keywords: Behaviour; Cannabinoid; Cannabis; Cortex; Development; Pregnancy; Rodent Model
Biological mechanisms of sleep and appetite through orexin and cannabinoid receptor interactions
Principal investigators: Laprairie, Robert
Development of Novel Type 1 Cannabinoid Receptor Positive Allosteric Modulators for Infantile Spasms
Principal investigators: Laprairie, Robert B
Keywords: Allosteric Modulation; Cannabinoid; Drug Discovery; Epilepsy; Molecular Biology; Neuroscience; Pharmacology; Structure-Activity Relationships; Type 1 Cannabinoid Receptor (Cb1r)
Biological mechanisms of sleep and appetite through orexin and cannabinoid receptor interactions
Principal investigators: Laprairie, Robert
Assessing the potential for using cannabidiol as a management option for anxiety in Alzheimer-dementia patients.
Principal investigators: Mousseau, Darrell D; Adams, Gheorghita C
Keywords: Alzheimer Disease; Anxiety; Cannabidiol; Pharmacokinetics; Safety & Tolerability
Exploration of the lesser-known cannabinoids of Cannabis sativa
Principal investigators: Laprairie, Robert
Novel Type 1 Cannabinoid Receptor Allosteric Modulators
Principal investigators: Laprairie, Robert B
Keywords: Cannabinoid; Drug Discovery; Molecular Biology; Neuroscience; Pharmacology; Structure-Activity Relationships; Type 1 Cannabinoid Receptor (Cb1)
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.